Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Malaria Diagnosed from Drop of Blood or Saliva

By LabMedica International staff writers
Posted on 13 Dec 2012
Scientists have developed a new method for diagnosing malaria based on measuring the activity of an enzyme called topoisomerase I from the Plasmodium parasite.

The technology on which the method is based is called Rolling Circle-Enhanced Enzyme Activity Detection (REEAD), which makes it possible to diagnose malaria from a single drop of blood or saliva. More...
This method is more time-effective and cost-effective than current diagnostic methods, and can be performed by personnel who have no specialized training. It can therefore be used in low-resource areas without the use of expensive equipment, clean water, or electricity.

The REEAD-based method distinguishes itself from other quick-test methods because it can measure whether a given Plasmodium infection is resistant to drugs. The newly developed technology is also the only quick-test method that makes it possible to diagnose the less common malaria parasites (P. ovale, P. knowlesi and P. malariae) in addition to the most common Plasmodium parasites (P. falciparum and P. vivax).

The high sensitivity is achieved by performing the REEAD technology within droplets surrounded by oil. The malaria parasites are distributed in the picoliter droplet, where they react effectively with the other components of the REEAD technology. The new method amplifies the signal from the malaria parasites since each parasite can give rise to more DNA molecules using the REEAD technology. Under the microscope, each DNA product is seen as a red dot.

The sensitivity, combined with its ability to detect infection in very small samples of blood or saliva, makes the method suitable for large-scale screening projects. This is of great importance in areas where the disease is close to being eradicated, and where it is therefore essential to identify and treat all patients infected with one of the above-mentioned parasites–even those who do not show symptoms of the disease.

Scientists who developed this method were led by Associate Professor Birgitta Knudsen, who is affiliated with the Interdisciplinary Nanoscience Centre (iNANO) and the Department of Molecular Biology and Genetics, Aarhus University (Denmark). Colleagues from Denmark (Department of Pathology and Department of Clinical Medicine, Aarhus University Hospital) and abroad (Duke University, University of Rome, University of St Andrews and University of Lyon) contributed to this project.

“This combination of molecular biologists, doctors, engineers, and statisticians has been important for our success in developing the new method,” said Prof. Knudsen.

The study was published in the November 2, 2012, edition of ACS Nano.

Related Links:
Aarhus University


New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
New
Gel Cards
DG Gel Cards
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: Erythrocyte Sedimentation Rate Sample Stability (Photo courtesy of ALCOR Scientific)

ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours

Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.